Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999). Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes. In 2004, Dr Jamieson joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation. In August 2010 he was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde.
A major area of focus for our research continues to be in the Chemistry-Biology-Medicine continuum. In this regard, we have a number of active programmes centred around hit and lead identification on disease targets and mechanisms in areas of significant societal need, particularly in diseases of ageing. Allied to our work in the medicinal chemistry sphere, we also have a keen interest in the development of novel, enabling synthetic methodologies to enhance the armamentarium of molecule makers working in our arena. We collaborate with groups and industrial partners locally, nationally and globally in order to effectively meet our research goals.
Sequence engineering to improve syringeability of high concentration mAb formulations Contributor23/11/2022Gyros Protein Technologies Visiting researcher1/6/2019Almac Sciences Visiting researcher31/5/2019Aldeyra Therapeutics Inc Consultant1/10/2018Arc Scientific Consultant1/1/2016Science Advances (Journal) Peer reviewer1/1/2014
More professional activities
Industrial CASE Account - University of Strathclyde 2022 | McTaggart, Eilidh Jamieson, Craig (Principal Investigator) Burley, Glenn (Co-investigator) McTaggart, Eilidh (Research Co-investigator) 01-Jan-2023 - 01-Jan-2027 NMR-BASE: Nuclear Magnetic Resonance for Biomolecule Analysis in Supported Environments Parkinson, John (Principal Investigator) Burley, Glenn (Co-investigator) Dufès, Christine (Co-investigator) Irving, Craig (Co-investigator) Jamieson, Craig (Co-investigator) Scott, Fraser (Co-investigator) Seib, Philipp (Co-investigator) Taladriz Sender, Andrea (Co-investigator) 01-Jan-2023 - 31-Jan-2024 Industrial CASE Account - University of Strathclyde 2022 | Jackson, Cara Beveridge, Rebecca (Principal Investigator) Jamieson, Craig (Co-investigator) Jackson, Cara (Research Co-investigator) 01-Jan-2022 - 01-Jan-2026 Industrial CASE Account - University of Strathclyde 2021 | Powell, Daniel Tomkinson, Nick (Principal Investigator) Jamieson, Craig (Co-investigator) Powell, Daniel (Research Co-investigator) 01-Jan-2022 - 01-Jan-2026 Development of a new antibody drug conjugate linker Jamieson, Craig (Principal Investigator) 01-Jan-2021 - 31-Jan-2025 Identifying New Drugs for the Treatment of Castrate Resistant Prostate Cancer Jamieson, Craig (Principal Investigator) Identifying New Drugs for the Treatment of Castrate Resistant Prostate Cancer: Targeting the Achilles' Heel of the Androgen Receptor 01-Jan-2020 - 31-Jan-2023